A recent national survey of adults conducted by the Bullfinch Group for CHPA further sheds light on consumer awareness, experiences, and perceptions of PE.
The Consumer Healthcare Products Association (CHPA) Educational Foundation and Family Dollar today announced the launch of a program to help Family Dollar shoppers make informed, educated choices about choosing and using over-the-counter (OTC) products and dietary supplements.
Bill proposes to make dietary supplements eligible expenses in FSA/HSA accounts, allowing consumers to use tax-preferred health savings to purchase wellness products.
Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville today released the below statement following the U.S. Food and Drug Administration (FDA) approving Opill®
CHPA thanks FDA for providing a process to give feedback from industry leveraging science and risk-based approaches to appropriately identify, assess and control (where needed) NDSRIs and preventing unacceptable levels of nitrosamines in drug products.
Industry appreciates this guidance to enable the assembly of suitable and successful OMORs. FDA must adopt standards and expectations consistent with the intent of OMUFA, rather than the NDA paradigm, with which it is very familiar.
CHPA appreciates this opportunity to comment on the Synthetic Dye Petition submitted to the California Department of Public Health requesting that a warning be placed on food and dietary supplement products related to adverse neurobehavioral effects purportedly associated with ingestion of synthetic food dyes.